NEW YORK, July 13, 2023 /PRNewswire/ — The marketing automation software market size is set to grow by USD 2,707.36 million from 2022 to 2027, progressing at a CAGR of 11.98% during the forecast period. Discover Application Software industry potential and make informed business decisions…
Month: July 2023
DUBLIN, July 13, 2023 /PRNewswire/ –The “Health Ingredients Market – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The global market for health ingredients is anticipated to experience substantial growth in the coming years, with a projected value…
NEW YORK, July 13, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Seagate Technology Holdings plc (“Seagate” or the “Company”) (NASDAQ: STX). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980….
NEW YORK , July 13, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Baxter International Inc. (“Baxter” or the “Company”) (NYSE: BAX). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The…
NEW YORK, July 13, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of FMC Corporation (“FMC” or the “Company”) (NYSE: FMC). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation…
NEW YORK, July 13, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Byrna Technologies Inc. (“Byrna” or the “Company”) (NASDAQ: BYRN). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The…
NEW YORK, July 13, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of ADC Therapeutics SA (“ADC” or the “Company”) (NYSE: ADCT). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The…
NEW YORK, July 13, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of AerCap Holdings N.V. (“AerCap” or the “Company”) (NYSE: AER). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The…
SÃO PAULO, 13 de julho de 2023 /PRNewswire/ — A GOL Linhas Aéreas Inteligentes S.A. (B3: GOLL4 e NYSE: GOL) (“GOL” ou “Companhia”), a maior companhia aérea doméstica do Brasil, divulga hoje uma Atualização ao Investidor sobre as suas expectativas para o segundo trimestre de 2023. As…
TOKYO, July 13, 2023 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced the European Medicines Agency (EMA) has accepted for regulatory review the company’s marketing authorization application (MAA) for zolbetuximab, a…